Gastric Cancer
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2006; 12(34): 5465-5472
Published online Sep 14, 2006. doi: 10.3748/wjg.v12.i34.5465
Table 2 cag A, vac A, IgG anti-H pylori and angiogenic factors in gastric cancer patients
IgG anti H pylori
cag A
vac A
n (%)n (%)n (%)n (%)n (%)n (%)
With IgG- (≤ 7 U/mL)With IgG+ (> 7 U/mL)Negative for cagAPositive for cagACytotoxic strains (s1; m1/2)Others (absent; s2m2)
TP expression1
029 (31)20 (69)24 (57)18 (43)24 (60)16 (40)
> 02 (25)6 (75)8 (80)2 (10)8 (80)2 (20)
p53 expression1
028 (25)24 (75)27 (60)18 (40)28 (65)15 (35)
> 03 (60)2 (40)5 (63)3 (37)4 (50)4 (50)
MVD (CD34)1
≤ 3727 (32)15 (68)16 (59)11 (41)15 (58)11 (42)
> 373 (21)11 (79)16 (64)9 (36)17 (71)7 (29)
VEGF-R1 expression1
≤ 2026 (29)15 (71)16 (59)11 (41)14 (54)12 (46)
> 205 (31)11 (69)15 (58)11 (42)17 (68)8 (32)
pVEGF levels
≤ 2629 (50)a9 (50)a10 (53)9 (47)11 (61)7 (39)
> 262 (13)a13 (87)a9 (60)6 (40)9 (60)6 (40)
sVEGF levels
≤ 43225 (29)12 (71)11 (61)7 (49)12 (71)5 (29)
> 4326 (32)13 (68)9 (47)10 (53)9 (47)10 (53)